Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma

World Journal of Surgery

Volumn 34, Issue 7, 2010, Pages 1481-1487

  Muller S ^a   Poehnert, D ^a   Muller J A ^a   Scheumann, G W F ^a   Koch, M ^b   Luck R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE; MALE; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; REGULATORY T LYMPHOCYTE; THYROID TUMOR;

ADULT; AGED; ANTIGENS, CD4; CARCINOMA, MEDULLARY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; THYROID NEOPLASMS;

EID: 77955471834     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0484-6     Document Type: Article

References (16)

1. DA Horwitz SG Zheng J Wang, et al. 2008 Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg Eur J Immunol 38 912 915 10.1002/eji.200738109 1:CAS:528:DC%2BD1cXlvFems7s%3D 18395858
2. I Kryczek R Liu G Wang, et al. 2009 FOXP3 defines regulatory T cells in human tumor and autoimmune disease Cancer Res 69 3995 4000 10.1158/0008-5472. CAN-08-3804 1:CAS:528:DC%2BD1MXltFOksbc%3D 19383912
3. H Imai M Saio K Nonaka, et al. 2007 Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma Cancer Sci 98 416 423 10.1111/j.1349-7006.2006.00385.x 1:CAS:528:DC%2BD2sXis1amtb8%3D 17270031 (Pubitemid 46195615)
4. TJ Curiel G Coukos L Zou, et al. 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942 949 10.1038/nm1093 1:CAS:528:DC%2BD2cXntFSkt7g%3D 15322536 (Pubitemid 39273735)
5. UK Liyanage TT Moore HG Joo, et al. 2002 Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2756 2761 1:CAS:528: DC%2BD38XmsF2ns7k%3D 12193750
6. KL Ling SE Pratap GJ Bates, et al. 2007 Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients Cancer Immunol 7 7
7. S Vikman R Sommaggio M De La Torre, et al. 2009 Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue Acta Oncol 48 391 400 10.1080/02841860802438495 1:CAS:528:DC%2BD1MXjt1ersb4%3D 18855160
8. A Frilling M-O Liedke 1998 Medulläres Schilddrüsenkarzinom: Sporadisch/Familiär. Wann und warum ein Screening? Internist 39 588 591 10.1007/s001080050216 1:STN:280:DyaK1czkt1Ckug%3D%3D 9677514 (Pubitemid 28297984)
9. C Eng D Clayton I Schuffenecker, et al. 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis JAMA 276 1575 1579 10.1001/jama.276.19.1575 1:STN:280:DyaK2s%2FnvVOgsg%3D%3D 8918855 (Pubitemid 26384740)
10. AWMF-Leitlinien-Register: Therapie maligner Schilddrüsentumoren Nr. 032/014
11. MA Skinner JA Moley WG Dilley, et al. 2005 Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A N Engl J Med 353 1105 1113 10.1056/NEJMoa043999 1:CAS:528:DC%2BD2MXhtVWhsbnO 16162881 (Pubitemid 41317433)
12. P Niccoli-Sire A Murat V Rohmer, et al. 2003 When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations? Surgery 134 1029 1036 10.1016/j.surg.2003.07.019 14668737 discussion 1036-1037 (Pubitemid 38010750)
13. ML Brandi RF Gagel A Angeli, et al. 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 5658 5671 10.1210/jc.86.12.5658 1:CAS:528:DC%2BD3MXptVyltLg%3D 11739416 (Pubitemid 33152604)
14. S Hinz L Pagerols-Raluy HH Oberg, et al. 2007 Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer Cancer Res 67 8344 8350 10.1158/0008-5472.CAN-06-3304 1:CAS:528: DC%2BD2sXpvFKju7Y%3D 17804750 (Pubitemid 47395173)
15. JY Niederkorn 2008 Emerging concepts in CD8+ T regulatory cells Curr Opin Immunol 20 327 331 10.1016/j.coi.2008.02.003 1:CAS:528:DC%2BD1cXns1aht7o%3D 18406591
16. SJ Roberts BY Ng RB Filler, et al. 2007 Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis Proc Natl Acad Sci USA 104 6770 6775 10.1073/pnas.0604982104 1:CAS:528:DC%2BD2sXkvFaltrg%3D 17412837 (Pubitemid 47175576)